Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| prostate androgen |
|
Studies on the characterization of rat prostate androgen receptors the rat prostate androgen receptor. Materials and methods. Chemicals .. acterization of androgen receptor from rat ventral prostate. Prostate androgen-regulated gene: a novel potential target for Growth analyses of PC3 cells after small interfering RNA (siRNA) treatment targeting the prostate androgen-regulated (PAR) gene. Current status of prostate androgen receptors -- Bradlow and Over the past eight years, many investigators have attempted to measure androgen receptors in human prostate cytosol and nuclear extracts. Keratinocyte growth factor in the rat ventral prostate: androgen Androgen-Regulated Expression of a Novel Member of the Aldo-Keto Reductase Superfamily in Regrowing Rat Prostate Endocrinology, September 1, 2000; Reproductive Biology and Endocrinology | Full text | A study of A study of the prostate, androgens and sexual activity of male rats . However, the modulation of androgen and AR levels in the prostate of healthy Sex Hormone-Binding Globulin Mediates Prostate Androgen Receptor -diol) have been implicated in prostate hyperplasia in man and dogs, but neither of these steroids bind to androgen receptors (ARs). Compare TMEPAI transmembrane prostate androgen induced RNA Find TMEPAI transmembrane prostate androgen induced RNA Antibodies from different companies by species reactivity, application, host species, PART1 - prostate androgen-regulated transcript 1 In this study, we determined the effect of soy isoflavones on the expression of prostate androgen-regulated transcript 1 ( PART-1), a newly discovered Estradiol Activates the Prostate Androgen Receptor and Prostate Estradiol Activates the Prostate Androgen Receptor and Prostate-specific Antigen Secretion through the Intermediacy of Sex Hormone-binding Globulin Effects of Prolactin on Prostate Androgen Receptors in Male Rats Available and exchangeable cytoplasmic and total nuclear KCl-extractable androgen binding sites in the prostate gland were determined using the synthetic Medical News: ASCO PROSTATE: Androgen Receptor Test Predicts Risk 26 -- A test that tallies the number of androgen receptors in a single prostate cancer cell may be an effective predictor of disease metastasis, IngentaConnect Digital expression profiles of the prostate The androgen receptor (AR) and cognate ligands regulate vital aspects of prostate cellular growth and function including proliferation, differentiation, The Journal of Urology : RACIAL DIFFERENCES IN PROSTATE ANDROGEN 7 To our knowledge no one has attempted to compare differences in prostate androgen between black and white Americans. Therefore, we measured androgen in Expression and regulation of prostate androgen regulated Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancer Genistein and Daidzein Downregulate Prostate Androgen-Regulated Genistein and Daidzein Downregulate Prostate Androgen-Regulated Transcript-1 (PART-1) Gene Expression Induced by Dihydrotestosterone in Human Prostate LNCaP Intracellular inactivation, reactivation and dynamic status of The dynamic status of the androgen receptor in prostate cells was studied The androgen receptor in the prostate appears to go through a dynamic process Our Stolen Future: Bisphenol A may interfere with treatment for In early stages of prostate cancer, treatment focuses on the androgen sensitivity of prostate cancer cells. These cells require serum androgen to ACS :: Hormone (Androgen Deprivation) Therapy The main androgens are testosterone and dihydrotestosterone (DHT). Androgens, produced mainly in the testicles, stimulate prostate cancer cells to grow. Androgen Receptor Outwits Prostate Cancer Drugs Most patients with metastatic prostate cancer receive drugs that block production of androgen, which promotes cancer cell proliferation. |
| prostate androgen |
|
prostate cancer articles prostate bone cancer prognosis prevention of prostate cancer prostate cancer and nutrition |